A phase 2 study of combined chemo-immunotherapy with cisplatin-pembrolizumab and radiation for unresectable vulvar squamous cell carcinoma

被引：0
|
作者：
Oladapo Yeku
Andrea L. Russo
Hang Lee
David Spriggs
机构：
[1] Harvard Medical School,Division of Hematology
[2] Massachusetts General Hospital,Oncology, Department of Medicine
[3] Harvard Medical School,Department of Radiation Oncology
[4] Massachusetts General Hospital,Biostatistics Center
[5] Harvard Medical School,undefined
[6] Massachusetts General Hospital,undefined
来源：
Journal of Translational Medicine | / 18卷
关键词：
Vulvar cancer; Pembrolizumab; Chemoradiation; Immunotherapy; Chemoimmunotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Targeting MUS81 endonuclease to enhance chemo-immunotherapy response in head and neck squamous cell carcinoma
    Suwaidan, Ali Abdulnabi
    Pasto, Anna
    McCarthy, Caitlin
    Pan, Teng
    Deng, Jinhai
    Dolcetti, Luigi
    Alfano, Giovanna
    Mustapha, Rami
    Monypenny, James
    Forster, Martin
    Ng, Tony
    CANCER RESEARCH, 2024, 84 (06)
  • [22] KEYNOTE-629: Phase 2 study of pembrolizumab for recurrent/metastatic or locally advanced unresectable cutaneous squamous cell carcinoma (cSCC).
    Grob, Jean Jacques
    Gonzalez, Rene
    Basset-Seguin, Nicole
    Schachter, Jacob
    Vornicova, Olga
    Bauman, Jessica Ruth
    Grange, Florent
    Meyer, Nicolas
    Piulats, Josep M.
    Zhang, Eric
    Gumuscu, Burak
    Swaby, Ramona F.
    Hughes, Brett Gordon Maxwell
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [23] Phase II study of IRInotecan after COmbined chemo-immunotherapy for extensive-disease small cell lung cancer: IRICO study
    Tomono, Hiromi
    Fukuda, Minoru
    Ikeda, Takaya
    Nagashima, Seiji
    Ono, Sawana
    Taniguchi, Hirokazu
    Gyotoku, Hiroshi
    Takemoto, Shinnosuke
    Yamaguchi, Hiroyuki
    Daa, Tokutaro
    Hisamatsu, Yasushi
    Morinaga, Ryotaro
    Tagawa, Ryuta
    Ogata, Ryosuke
    Dotsu, Yosuke
    Senju, Hiroaki
    Soda, Hiroshi
    Nakatomi, Katsumi
    Sugasaki, Nanae
    Kinoshita, Akitoshi
    RESPIROLOGY, 2023, 28 : 302 - 302
  • [24] Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trial
    Jeffrey A. How
    Amir A. Jazaeri
    Pamela T. Soliman
    Nicole D. Fleming
    Jing Gong
    Sarina A. Piha-Paul
    Filip Janku
    Bettzy Stephen
    Aung Naing
    Scientific Reports, 11
  • [25] Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trial
    How, Jeffrey A.
    Jazaeri, Amir A.
    Soliman, Pamela T.
    Fleming, Nicole D.
    Gong, Jing
    Piha-Paul, Sarina A.
    Janku, Filip
    Stephen, Bettzy
    Naing, Aung
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [26] KEYNOTE-629: Phase II study of pembrolizumab for recurrent/metastatic or locally advanced unresectable cutaneous squamous cell carcinoma
    Grob, Jean-Jacques
    Gonzalez Mendoza, Rene
    Basset-Seguin, Nicole
    Schachter, Jacob
    Vornicova, Olga
    Bauman, Jessica
    Grange, Florent
    Meyer, Nicolas
    Piulats, Josep
    Zhang, Pingye
    Gumuscu, Burak
    Swaby, Ramona
    Hughes, Brett G. M.
    CANCER RESEARCH, 2019, 79 (13)
  • [27] Phase I study of cisplatin analogue nedaplatin (254-S) and paclitaxel in patients with unresectable squamous cell carcinoma
    I Sekine
    H Nokihara
    A Horiike
    N Yamamoto
    H Kunitoh
    Y Ohe
    T Tamura
    T Kodama
    N Saijo
    British Journal of Cancer, 2004, 90 : 1125 - 1128
  • [28] Phase I study of cisplatin analogue nedaplatin (254-S) and paclitaxel in patients with unresectable squamous cell carcinoma
    Sekine, I
    Nokihara, H
    Horiike, A
    Yamamoto, N
    Kunitoh, H
    Ohe, Y
    Tamura, T
    Kodama, T
    Saijo, N
    BRITISH JOURNAL OF CANCER, 2004, 90 (06) : 1125 - 1128
  • [29] Pembrolizumab as first line therapy in patients with unresectable squamous cell carcinoma of the skin: Interim results of the phase 2 CARSKIN trial
    Maubec, Eve
    Boubaya, Marouane
    Petrow, Peter
    Basset-Seguin, Nicole
    Grob, Jean-Jacques
    Dreno, Brigitte
    Scheer-Senyarich, Isabelle
    Helfen, Sabine
    De Quatrebarbes, Julie
    Poirier, Elodie
    Deschamps, Lydia
    Alloux, Celine
    Lopez, Isabelle
    Cherbal, Soufian
    Beylot-Barry, Marie
    Grange, Florent
    Schischmanoff, Olivier
    Tibi, Annick
    Levy, Vincent
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [30] Efficacy and safety of pembrolizumab for patients with previously treated advanced vulvar squamous cell carcinoma: Results from the phase 2 KEYNOTE-158 study
    Shapira-Frommer, Ronnie
    Mileshkin, Linda
    Manzyuk, Ludmila
    Penel, Nicolas
    Burge, Matthew
    Piha-Paul, Sarina A.
    Girda, Eugenia
    Martin, Jose A. Lopez
    Van Dongen, Marloes G. J.
    Italiano, Antoine
    Xu, Lei
    Jin, Fan
    Norwood, Kevin
    Ott, Patrick A.
    GYNECOLOGIC ONCOLOGY, 2022, 166 (02) : 211 - 218
12345